Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-MSC1 in Critical Limb Ischemia
NCT03994666Phase 2Unknown
- Sponsor
- CHU de Reims
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HB-MSC1 in critical limb ischemia (CLI), sponsored by CHU de Reims. Status: unknown.
02
Drugs
HB-MSC1
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03994666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994666.